Vectura Group PLC (VEC.L)
70.00GBp
7 Dec 2018
1.00 (+1.45%)
69.00
69.25
70.55
68.65
843,373
1,197,431
127.22
65.85
About
Overall
| Beta: | 0.41 |
| Market Cap(Mil.): | £705.16 |
| Shares Outstanding(Mil.): | 679.34 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| VEC.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 31.13 | 33.63 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | 15.55 | 15.02 |
| ROE: | -- | 16.92 | 16.60 |
Vectura drops severe asthma treatment after poor trial results
Britain's Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition.
Vectura drops severe asthma treatment after poor trial results
Britain's Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition.
UPDATE 2-Vectura drops severe asthma treatment after poor trial results
* Shares fall more than 10 percent (Adds CEO, analyst comment, share movement)
Vectura to stop developing asthma treatment after late-stage failure
Nov 26 British drugmaker Vectura Group Plc said on Monday it would stop developing its treatment for severe uncontrolled asthma after the drug-device combination failed to meet the main goal of a late-stage study.
UPDATE 1-Vectura reviewing drug stockpiles as no-deal Brexit looms
Sept 11 British drugmaker Vectura Group Plc is reviewing its stockpiles of drugs and key components as part of its mitigation plan for a "no-deal" Brexit and warned on Tuesday of a potential disruption to supply chains and higher costs.
Vectura reviewing drug stockpiles as no-deal Brexit looms
Sept 11 Vectura Group Plc is reviewing its stockpiles of drugs and key components as part of its plan for a "no-deal" Brexit, the British drugmaker said on Tuesday, and warned of a potential disruption to supply chains and higher costs.
Earnings vs. 
Estimates
- Should You Ditch GlaxoSmithKline plc And Buy Vectura Group PLC And SkyePharma PLC?
- Are Vectura Group PLC, AstraZeneca plc And Lookers PLC 'Screaming Buys'?
- Are Vectura Group PLC And Circassia Pharmaceuticals PLC Better Buys Than GlaxoSmithKline plc?
- Why Vectura Group PLC Could Be The Perfect Partner For AstraZeneca plc In Your Portfolio
- Profit From The Biotech Boom With Vectura Group PLC, Hikma Pharmaceuticals Plc And Indivior PLC